We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+28.53%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.3B
AUM Growth
+$4.26B
(+43%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
13.37%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
2,145
New
560
Increased
472
Reduced
391
Closed
662
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$139M |
| 2 |
Procter & Gamble
PG
|
+$118M |
| 3 |
Teleflex
TFX
|
+$90.1M |
| 4 |
Microsoft
MSFT
|
+$89.4M |
| 5 |
UBS Group
UBS
|
+$77.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$203M |
| 2 |
AGN
Allergan plc
AGN
|
+$177M |
| 3 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$118M |
| 4 |
Amazon
AMZN
|
+$115M |
| 5 |
Linde
LIN
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.29% |
| 2 | Consumer Discretionary | 15.87% |
| 3 | Technology | 12.26% |
| 4 | Financials | 12.01% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Air Products & Chemicals
APD
$66.3B
| $2.06M | 0.01% |
8,549
-955
| -10% | -$218K |
|
777
State Street Industrial Select Sector SPDR ETF
XLI
$33.9B
| $2.06M | 0.01% |
30,007
+23,382
| +353% | +$1.52M |
|
778
Xylem
XYL
$28.5B
| $2.06M | 0.01% |
31,721
+31,261
| +6,796% | +$2.06M |
|
779
Sempra
SRE
$60.8B
| $2.05M | 0.01% |
35,012
+33,382
| +2,048% | +$2.05M |
|
780
Donnelley Financial Solutions
DFIN
$1.21B
| $2.05M | 0.01% |
243,893
-173,371
| -42% | -$1.25M |
|
781
Taylor Morrison
TMHC
| $2.05M | 0.01% |
106,064
-190,649
| -64% | -$3M |
|
782
Cannae Holdings
CNNE
$647M
| $2.04M | 0.01% |
49,754
+41,120
| +476% | +$1.41M |
|
|
ARNA
783
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $2.04M | 0.01% |
+32,445
| New | +$1.79M |
|
784
Innoviva
INVA
$1.58B
| $2.04M | 0.01% |
145,808
-18,311
| -11% | -$249K |
|
785
Icon
ICLR
$12.8B
| $2.03M | 0.01% |
12,028
-14,511
| -55% | -$2.29M |
|
786
GSK
GSK
$103B
| $2.02M | 0.01% |
+39,717
| New | +$2.04M |
|
787
Chemed
CHE
$6.78B
| $2.02M | 0.01% |
4,479
-1,638
| -27% | -$731K |
|
788
Generac Holdings
GNRC
$11.9B
| $2.02M | 0.01% |
+16,573
| New | +$1.75M |
|
789
Travere Therapeutics
TVTX
$5.33B
| $2.02M | 0.01% |
+98,976
| New | +$1.58M |
|
790
Ambarella
AMBA
$2.99B
| $2.01M | 0.01% |
+43,964
| New | +$2.26M |
|
791
Banco Santander Chile
BSAC
$15.8B
| $2.01M | 0.01% |
122,636
+46,263
| +61% | +$761K |
|
792
Merit Medical Systems
MMSI
$4.43B
| $1.99M | 0.01% |
+43,595
| New | +$1.76M |
|
793
Macy's
M
$6.15B
| $1.99M | 0.01% |
+288,522
| New | +$1.78M |
|
794
Ingles Markets
IMKTA
$1.63B
| $1.98M | 0.01% |
+46,023
| New | +$1.87M |
|
795
Textron
TXT
$16.6B
| $1.98M | 0.01% |
+60,203
| New | +$1.78M |
|
796
Axos Financial
AX
$5.45B
| $1.98M | 0.01% |
+89,521
| New | +$1.82M |
|
797
Varonis Systems
VRNS
$5.25B
| $1.98M | 0.01% |
+66,990
| New | +$1.68M |
|
798
RBC Bearings
RBC
$18.8B
| $1.98M | 0.01% |
14,733
+572
| +4% | +$72.9K |
|
|
DAO
799
Youdao
DAO
$1.85B
| $1.97M | 0.01% |
+52,520
| New | +$1.29M |
|
800
OrthoPediatrics
KIDS
$485M
| $1.97M | 0.01% |
+44,915
| New | +$2.02M |
|
Similar funds
Marshall Wace's Q2 2020 Portfolio in Review
As of Q2 2020, Marshall Wace held 2,145 positions worth $14.3B, up 43% from $10B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $1.91B of net new capital in Q2 2020, opening 560 new positions and adding to 472 existing holdings. Its largest new stake was JPMorgan Chase: 783,355 shares worth $73.7M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was PayPal, an estimated $203M trimmed.
- Marshall Wace's largest Q2 2020 buy was JPMorgan Chase: 783,355 shares worth $73.7M.
- Marshall Wace added most to T-Mobile US in Q2 2020, an estimated $139M increase.
- Marshall Wace's biggest Q2 2020 reduction was PayPal, cutting an estimated $203M.
- Marshall Wace fully exited Allergan plc in Q2 2020, selling an estimated $177M.
- Marshall Wace's ten largest holdings make up 16% of its $14.3B portfolio in Q2 2020.
- Marshall Wace opened 560 new positions and closed 662 in Q2 2020.
- Marshall Wace's portfolio value rose 43% quarter-over-quarter to $14.3B.
Based on Marshall Wace's 13F filing for Q2 2020, filed 13 Aug 2020.